Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LABP

Landos Biopharma (LABP) Stock Price, News & Analysis

Landos Biopharma logo

About Landos Biopharma Stock (NASDAQ:LABP)

Advanced Chart

Key Stats

Today's Range
$22.75
$22.94
50-Day Range
$21.51
$22.93
52-Week Range
$2.50
$22.94
Volume
50,800 shs
Average Volume
19,700 shs
Market Capitalization
$71.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LABP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter.

LABP Stock News Headlines

Gold is soaring. Here’s how to get paid from it
Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.
AbbVie Completes Acquisition of Landos Biopharma
See More Headlines

LABP Stock Analysis - Frequently Asked Questions

Landos Biopharma, Inc. (NASDAQ:LABP) posted its quarterly earnings data on Friday, May, 12th. The company reported ($0.90) EPS for the quarter, beating the consensus estimate of ($1.00) by $0.10.

Landos Biopharma shares reverse split on Friday, May 26th 2023.The 1-10 reverse split was announced on Friday, May 26th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 26th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Landos Biopharma (LABP) raised $101 million in an IPO on Thursday, February 4th 2021. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, Jefferies and SVB Leerink acted as the underwriters for the IPO and Raymond James was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Landos Biopharma investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Adobe (ADBE), e.l.f. Beauty (ELF), Jabil (JBL) and Arista Networks (ANET).

Company Calendar

Last Earnings
5/12/2023
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LABP
CIK
1785345
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.99)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$21.93 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-73.00%
Return on Assets
-63.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.43
Quick Ratio
4.43

Sales & Book Value

Annual Sales
$18 million
Price / Sales
3.99
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.41 per share
Price / Book
3.09

Miscellaneous

Outstanding Shares
3,130,000
Free Float
3,085,000
Market Cap
$71.77 million
Optionable
Not Optionable
Beta
0.14
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:LABP) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners